SCHEMBL4632640

SCHEMBL4632640

CC(=NO)C(c1cccc(Nc2cc(C)nc3ccccc23)c1)N1CCC(Cc2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 12/20 0.47
NPC1 O15118 2/20 0.44
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
GUSB P08236 1/20 0.40
MAPT P10636 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775153 0.81 ACP1 (0.47) ACP1NPC1TSHRHTTADRA2A
SCHEMBL4831965 0.81 GRIN2B (0.51) ACP1
SCHEMBL4632684 0.78 ACP1 (0.49) ACP1NPC1TSHRHTT
SCHEMBL4632685 0.78 ACP1 (0.49) ACP1NPC1TSHRHTT
SCHEMBL4825128 0.76 ACP1 (0.59) ACP1NPC1HTTMAPT
SCHEMBL4633362 0.74 ACP1 (0.53) ACP1
SCHEMBL4632755 0.73 NPC1 (0.55) ACP1NPC1
SCHEMBL4632713 0.73 HTR1A (0.57) ACP1TSHRHTT
SCHEMBL4633305 0.72 TMEM97 (0.56) ACP1TSHRHTT
SCHEMBL4834046 0.72 SLC6A2 (0.54) ACP1NPC1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603884-A4 PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE, AND NAPHTHALENE UROTENSIN-II RECEPTOR ANTAGONISTS. ENCYSIVE PHARMACEUTICALS INC (US) 2008-05-28 EP disclosed
EP-1603884-A2 PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE, AND NAPHTHALENE UROTENSIN-II RECEPTOR ANTAGONISTS. ENCYSIVE PHARMACEUTICALS INC. (US) 2005-12-14 EP disclosed
WO-2004078114-A2 PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE, AND NAPHTHALENE UROTENSIN-II RECEPTOR ANTAGONISTS. ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-16 WO disclosed